Clinical outcome of renal tubular damage in chronic heart failure

Aims Both reduced glomerular filtration and increased urinary albumin excretion independently determine outcome in patients with chronic heart failure (HF). However, tubulo-interstitial injury might indicate renal damage, even in the presence of normal glomerular filtration. We studied the relations...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal 2011-11, Vol.32 (21), p.2705-2712
Hauptverfasser: Damman, Kevin, Masson, Serge, Hillege, Hans L., Maggioni, Aldo P., Voors, Adriaan A., Opasich, Cristina, van Veldhuisen, Dirk J., Montagna, Laura, Cosmi, Franco, Tognoni, Gianni, Tavazzi, Luigi, Latini, Roberto
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2712
container_issue 21
container_start_page 2705
container_title European heart journal
container_volume 32
creator Damman, Kevin
Masson, Serge
Hillege, Hans L.
Maggioni, Aldo P.
Voors, Adriaan A.
Opasich, Cristina
van Veldhuisen, Dirk J.
Montagna, Laura
Cosmi, Franco
Tognoni, Gianni
Tavazzi, Luigi
Latini, Roberto
description Aims Both reduced glomerular filtration and increased urinary albumin excretion independently determine outcome in patients with chronic heart failure (HF). However, tubulo-interstitial injury might indicate renal damage, even in the presence of normal glomerular filtration. We studied the relationship between tubular damage, glomerular filtration, urinary albumin excretion, and outcome in HF patients. Methods and results In 2130 patients participating in the GISSI-HF trial, we measured urinary albumin-to-creatinine ratio (UACR), estimated glomerular filtration rate (eGFR), and three urinary markers of tubular damage: N-acetyl-beta-d-glucosaminidase (NAG), kidney injury molecule 1 (KIM-1), and neutrophil gelatinase-associated lipocalin (NGAL). We assessed the relationship between the individual tubular damage markers and the combined endpoint of all-cause mortality and HF hospitalizations. Mean age was 67 ± 11 years, and 21% were female. Urinary NAG 13.7 (7.8-22) U/gCr, KIM-1 1939 (671-3871) ng/gCr, and NGAL 36 (14-94) µg/gCr were markedly elevated above normal levels. All individual tubular markers were independently associated with the combined endpoint: NAG: adjusted hazard ratio (HR) 1.22; 95% confidence interval (CI), 1.10-1.36; P< 0.001, KIM-1 HR 1.13; 95% CI, 1.02-1.24; P= 0.018 and NGAL HR 1.10; 95% CI, 1.00-1.20; P= 0.042; all per log standard deviation increase). Even in patients with a normal eGFR, increased tubular markers were related to a poorer outcome. The combination of impaired eGFR, increased UACR, and high NAG was associated with a HR of 3.00; 95% CI, 2.29-3.95; P< 0.001, compared with those without these abnormalities. Conclusion Tubular damage is related to a poor clinical outcome in HF patients even when eGFR is normal. ClinicalTrials.gov Identifier: NCT00336336 (for the main study).
doi_str_mv 10.1093/eurheartj/ehr190
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_902087554</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/eurheartj/ehr190</oup_id><sourcerecordid>902087554</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-4a50802d29460b377d55264e98568c971694cfddc824d15277c8440dbf7aa2803</originalsourceid><addsrcrecordid>eNqFkDtPwzAURi0EoqWwMyEviAGF2q6fI6p4SZVYQGKLHNuhqZK42PHAv8eQUkamK12d77u6B4BzjG4wUou5S2HtdBg2c7cOWKEDMMWMkEJxyg7BFGHFCs7l2wScxLhBCEmO-TGYEMw5J1RNwe2ybfrG6Bb6NBjfOehrGFyfF0OqUqsDtLrT7w42PTTr4DMMf27CWjdtCu4UHNW6je5sN2fg9f7uZflYrJ4fnpa3q8JQQYaCaoYkIpYoylG1EMIyRjh1SjIujRKYK2pqa40k1OYnhDCSUmSrWmhNJFrMwNXYuw3-I7k4lF0TjWtb3TufYqkQQVIwRjOJRtIEH2NwdbkNTafDZ4lR-e2t3HsrR285crErT1Xn7D7wKyoDlztAx2yrDro3TfzjKF8IJkXmrkfOp-3_Z78AbZiHNQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>902087554</pqid></control><display><type>article</type><title>Clinical outcome of renal tubular damage in chronic heart failure</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Damman, Kevin ; Masson, Serge ; Hillege, Hans L. ; Maggioni, Aldo P. ; Voors, Adriaan A. ; Opasich, Cristina ; van Veldhuisen, Dirk J. ; Montagna, Laura ; Cosmi, Franco ; Tognoni, Gianni ; Tavazzi, Luigi ; Latini, Roberto</creator><creatorcontrib>Damman, Kevin ; Masson, Serge ; Hillege, Hans L. ; Maggioni, Aldo P. ; Voors, Adriaan A. ; Opasich, Cristina ; van Veldhuisen, Dirk J. ; Montagna, Laura ; Cosmi, Franco ; Tognoni, Gianni ; Tavazzi, Luigi ; Latini, Roberto</creatorcontrib><description>Aims Both reduced glomerular filtration and increased urinary albumin excretion independently determine outcome in patients with chronic heart failure (HF). However, tubulo-interstitial injury might indicate renal damage, even in the presence of normal glomerular filtration. We studied the relationship between tubular damage, glomerular filtration, urinary albumin excretion, and outcome in HF patients. Methods and results In 2130 patients participating in the GISSI-HF trial, we measured urinary albumin-to-creatinine ratio (UACR), estimated glomerular filtration rate (eGFR), and three urinary markers of tubular damage: N-acetyl-beta-d-glucosaminidase (NAG), kidney injury molecule 1 (KIM-1), and neutrophil gelatinase-associated lipocalin (NGAL). We assessed the relationship between the individual tubular damage markers and the combined endpoint of all-cause mortality and HF hospitalizations. Mean age was 67 ± 11 years, and 21% were female. Urinary NAG 13.7 (7.8-22) U/gCr, KIM-1 1939 (671-3871) ng/gCr, and NGAL 36 (14-94) µg/gCr were markedly elevated above normal levels. All individual tubular markers were independently associated with the combined endpoint: NAG: adjusted hazard ratio (HR) 1.22; 95% confidence interval (CI), 1.10-1.36; P&lt; 0.001, KIM-1 HR 1.13; 95% CI, 1.02-1.24; P= 0.018 and NGAL HR 1.10; 95% CI, 1.00-1.20; P= 0.042; all per log standard deviation increase). Even in patients with a normal eGFR, increased tubular markers were related to a poorer outcome. The combination of impaired eGFR, increased UACR, and high NAG was associated with a HR of 3.00; 95% CI, 2.29-3.95; P&lt; 0.001, compared with those without these abnormalities. Conclusion Tubular damage is related to a poor clinical outcome in HF patients even when eGFR is normal. ClinicalTrials.gov Identifier: NCT00336336 (for the main study).</description><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/eurheartj/ehr190</identifier><identifier>PMID: 21666249</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Acetylglucosaminidase - urine ; Acute-Phase Proteins - urine ; Aged ; Albuminuria ; Biological and medical sciences ; Cardio-Renal Syndrome - physiopathology ; Cardio-Renal Syndrome - urine ; Cardiology. Vascular system ; Chronic Disease ; Female ; Glomerular Filtration Rate - physiology ; Heart ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Hepatitis A Virus Cellular Receptor 1 ; Humans ; Kidney Tubules - physiopathology ; Lipocalin-2 ; Lipocalins - urine ; Male ; Medical sciences ; Membrane Glycoproteins - urine ; Middle Aged ; Multicenter Studies as Topic ; Proto-Oncogene Proteins - urine ; Randomized Controlled Trials as Topic ; Receptors, Virus</subject><ispartof>European heart journal, 2011-11, Vol.32 (21), p.2705-2712</ispartof><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2011. For permissions please email: journals.permissions@oup.com 2011</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-4a50802d29460b377d55264e98568c971694cfddc824d15277c8440dbf7aa2803</citedby><cites>FETCH-LOGICAL-c472t-4a50802d29460b377d55264e98568c971694cfddc824d15277c8440dbf7aa2803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24637587$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21666249$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Damman, Kevin</creatorcontrib><creatorcontrib>Masson, Serge</creatorcontrib><creatorcontrib>Hillege, Hans L.</creatorcontrib><creatorcontrib>Maggioni, Aldo P.</creatorcontrib><creatorcontrib>Voors, Adriaan A.</creatorcontrib><creatorcontrib>Opasich, Cristina</creatorcontrib><creatorcontrib>van Veldhuisen, Dirk J.</creatorcontrib><creatorcontrib>Montagna, Laura</creatorcontrib><creatorcontrib>Cosmi, Franco</creatorcontrib><creatorcontrib>Tognoni, Gianni</creatorcontrib><creatorcontrib>Tavazzi, Luigi</creatorcontrib><creatorcontrib>Latini, Roberto</creatorcontrib><title>Clinical outcome of renal tubular damage in chronic heart failure</title><title>European heart journal</title><addtitle>Eur Heart J</addtitle><description>Aims Both reduced glomerular filtration and increased urinary albumin excretion independently determine outcome in patients with chronic heart failure (HF). However, tubulo-interstitial injury might indicate renal damage, even in the presence of normal glomerular filtration. We studied the relationship between tubular damage, glomerular filtration, urinary albumin excretion, and outcome in HF patients. Methods and results In 2130 patients participating in the GISSI-HF trial, we measured urinary albumin-to-creatinine ratio (UACR), estimated glomerular filtration rate (eGFR), and three urinary markers of tubular damage: N-acetyl-beta-d-glucosaminidase (NAG), kidney injury molecule 1 (KIM-1), and neutrophil gelatinase-associated lipocalin (NGAL). We assessed the relationship between the individual tubular damage markers and the combined endpoint of all-cause mortality and HF hospitalizations. Mean age was 67 ± 11 years, and 21% were female. Urinary NAG 13.7 (7.8-22) U/gCr, KIM-1 1939 (671-3871) ng/gCr, and NGAL 36 (14-94) µg/gCr were markedly elevated above normal levels. All individual tubular markers were independently associated with the combined endpoint: NAG: adjusted hazard ratio (HR) 1.22; 95% confidence interval (CI), 1.10-1.36; P&lt; 0.001, KIM-1 HR 1.13; 95% CI, 1.02-1.24; P= 0.018 and NGAL HR 1.10; 95% CI, 1.00-1.20; P= 0.042; all per log standard deviation increase). Even in patients with a normal eGFR, increased tubular markers were related to a poorer outcome. The combination of impaired eGFR, increased UACR, and high NAG was associated with a HR of 3.00; 95% CI, 2.29-3.95; P&lt; 0.001, compared with those without these abnormalities. Conclusion Tubular damage is related to a poor clinical outcome in HF patients even when eGFR is normal. ClinicalTrials.gov Identifier: NCT00336336 (for the main study).</description><subject>Acetylglucosaminidase - urine</subject><subject>Acute-Phase Proteins - urine</subject><subject>Aged</subject><subject>Albuminuria</subject><subject>Biological and medical sciences</subject><subject>Cardio-Renal Syndrome - physiopathology</subject><subject>Cardio-Renal Syndrome - urine</subject><subject>Cardiology. Vascular system</subject><subject>Chronic Disease</subject><subject>Female</subject><subject>Glomerular Filtration Rate - physiology</subject><subject>Heart</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Hepatitis A Virus Cellular Receptor 1</subject><subject>Humans</subject><subject>Kidney Tubules - physiopathology</subject><subject>Lipocalin-2</subject><subject>Lipocalins - urine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - urine</subject><subject>Middle Aged</subject><subject>Multicenter Studies as Topic</subject><subject>Proto-Oncogene Proteins - urine</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Receptors, Virus</subject><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkDtPwzAURi0EoqWwMyEviAGF2q6fI6p4SZVYQGKLHNuhqZK42PHAv8eQUkamK12d77u6B4BzjG4wUou5S2HtdBg2c7cOWKEDMMWMkEJxyg7BFGHFCs7l2wScxLhBCEmO-TGYEMw5J1RNwe2ybfrG6Bb6NBjfOehrGFyfF0OqUqsDtLrT7w42PTTr4DMMf27CWjdtCu4UHNW6je5sN2fg9f7uZflYrJ4fnpa3q8JQQYaCaoYkIpYoylG1EMIyRjh1SjIujRKYK2pqa40k1OYnhDCSUmSrWmhNJFrMwNXYuw3-I7k4lF0TjWtb3TufYqkQQVIwRjOJRtIEH2NwdbkNTafDZ4lR-e2t3HsrR285crErT1Xn7D7wKyoDlztAx2yrDro3TfzjKF8IJkXmrkfOp-3_Z78AbZiHNQ</recordid><startdate>20111101</startdate><enddate>20111101</enddate><creator>Damman, Kevin</creator><creator>Masson, Serge</creator><creator>Hillege, Hans L.</creator><creator>Maggioni, Aldo P.</creator><creator>Voors, Adriaan A.</creator><creator>Opasich, Cristina</creator><creator>van Veldhuisen, Dirk J.</creator><creator>Montagna, Laura</creator><creator>Cosmi, Franco</creator><creator>Tognoni, Gianni</creator><creator>Tavazzi, Luigi</creator><creator>Latini, Roberto</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20111101</creationdate><title>Clinical outcome of renal tubular damage in chronic heart failure</title><author>Damman, Kevin ; Masson, Serge ; Hillege, Hans L. ; Maggioni, Aldo P. ; Voors, Adriaan A. ; Opasich, Cristina ; van Veldhuisen, Dirk J. ; Montagna, Laura ; Cosmi, Franco ; Tognoni, Gianni ; Tavazzi, Luigi ; Latini, Roberto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-4a50802d29460b377d55264e98568c971694cfddc824d15277c8440dbf7aa2803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Acetylglucosaminidase - urine</topic><topic>Acute-Phase Proteins - urine</topic><topic>Aged</topic><topic>Albuminuria</topic><topic>Biological and medical sciences</topic><topic>Cardio-Renal Syndrome - physiopathology</topic><topic>Cardio-Renal Syndrome - urine</topic><topic>Cardiology. Vascular system</topic><topic>Chronic Disease</topic><topic>Female</topic><topic>Glomerular Filtration Rate - physiology</topic><topic>Heart</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Hepatitis A Virus Cellular Receptor 1</topic><topic>Humans</topic><topic>Kidney Tubules - physiopathology</topic><topic>Lipocalin-2</topic><topic>Lipocalins - urine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - urine</topic><topic>Middle Aged</topic><topic>Multicenter Studies as Topic</topic><topic>Proto-Oncogene Proteins - urine</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Receptors, Virus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Damman, Kevin</creatorcontrib><creatorcontrib>Masson, Serge</creatorcontrib><creatorcontrib>Hillege, Hans L.</creatorcontrib><creatorcontrib>Maggioni, Aldo P.</creatorcontrib><creatorcontrib>Voors, Adriaan A.</creatorcontrib><creatorcontrib>Opasich, Cristina</creatorcontrib><creatorcontrib>van Veldhuisen, Dirk J.</creatorcontrib><creatorcontrib>Montagna, Laura</creatorcontrib><creatorcontrib>Cosmi, Franco</creatorcontrib><creatorcontrib>Tognoni, Gianni</creatorcontrib><creatorcontrib>Tavazzi, Luigi</creatorcontrib><creatorcontrib>Latini, Roberto</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Damman, Kevin</au><au>Masson, Serge</au><au>Hillege, Hans L.</au><au>Maggioni, Aldo P.</au><au>Voors, Adriaan A.</au><au>Opasich, Cristina</au><au>van Veldhuisen, Dirk J.</au><au>Montagna, Laura</au><au>Cosmi, Franco</au><au>Tognoni, Gianni</au><au>Tavazzi, Luigi</au><au>Latini, Roberto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical outcome of renal tubular damage in chronic heart failure</atitle><jtitle>European heart journal</jtitle><addtitle>Eur Heart J</addtitle><date>2011-11-01</date><risdate>2011</risdate><volume>32</volume><issue>21</issue><spage>2705</spage><epage>2712</epage><pages>2705-2712</pages><issn>0195-668X</issn><eissn>1522-9645</eissn><abstract>Aims Both reduced glomerular filtration and increased urinary albumin excretion independently determine outcome in patients with chronic heart failure (HF). However, tubulo-interstitial injury might indicate renal damage, even in the presence of normal glomerular filtration. We studied the relationship between tubular damage, glomerular filtration, urinary albumin excretion, and outcome in HF patients. Methods and results In 2130 patients participating in the GISSI-HF trial, we measured urinary albumin-to-creatinine ratio (UACR), estimated glomerular filtration rate (eGFR), and three urinary markers of tubular damage: N-acetyl-beta-d-glucosaminidase (NAG), kidney injury molecule 1 (KIM-1), and neutrophil gelatinase-associated lipocalin (NGAL). We assessed the relationship between the individual tubular damage markers and the combined endpoint of all-cause mortality and HF hospitalizations. Mean age was 67 ± 11 years, and 21% were female. Urinary NAG 13.7 (7.8-22) U/gCr, KIM-1 1939 (671-3871) ng/gCr, and NGAL 36 (14-94) µg/gCr were markedly elevated above normal levels. All individual tubular markers were independently associated with the combined endpoint: NAG: adjusted hazard ratio (HR) 1.22; 95% confidence interval (CI), 1.10-1.36; P&lt; 0.001, KIM-1 HR 1.13; 95% CI, 1.02-1.24; P= 0.018 and NGAL HR 1.10; 95% CI, 1.00-1.20; P= 0.042; all per log standard deviation increase). Even in patients with a normal eGFR, increased tubular markers were related to a poorer outcome. The combination of impaired eGFR, increased UACR, and high NAG was associated with a HR of 3.00; 95% CI, 2.29-3.95; P&lt; 0.001, compared with those without these abnormalities. Conclusion Tubular damage is related to a poor clinical outcome in HF patients even when eGFR is normal. ClinicalTrials.gov Identifier: NCT00336336 (for the main study).</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>21666249</pmid><doi>10.1093/eurheartj/ehr190</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0195-668X
ispartof European heart journal, 2011-11, Vol.32 (21), p.2705-2712
issn 0195-668X
1522-9645
language eng
recordid cdi_proquest_miscellaneous_902087554
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Acetylglucosaminidase - urine
Acute-Phase Proteins - urine
Aged
Albuminuria
Biological and medical sciences
Cardio-Renal Syndrome - physiopathology
Cardio-Renal Syndrome - urine
Cardiology. Vascular system
Chronic Disease
Female
Glomerular Filtration Rate - physiology
Heart
Heart failure, cardiogenic pulmonary edema, cardiac enlargement
Hepatitis A Virus Cellular Receptor 1
Humans
Kidney Tubules - physiopathology
Lipocalin-2
Lipocalins - urine
Male
Medical sciences
Membrane Glycoproteins - urine
Middle Aged
Multicenter Studies as Topic
Proto-Oncogene Proteins - urine
Randomized Controlled Trials as Topic
Receptors, Virus
title Clinical outcome of renal tubular damage in chronic heart failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T20%3A53%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20outcome%20of%20renal%20tubular%20damage%20in%20chronic%20heart%20failure&rft.jtitle=European%20heart%20journal&rft.au=Damman,%20Kevin&rft.date=2011-11-01&rft.volume=32&rft.issue=21&rft.spage=2705&rft.epage=2712&rft.pages=2705-2712&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/eurheartj/ehr190&rft_dat=%3Cproquest_cross%3E902087554%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=902087554&rft_id=info:pmid/21666249&rft_oup_id=10.1093/eurheartj/ehr190&rfr_iscdi=true